Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Oshrat Raz"'
Publikováno v:
Experimental Hematology. 85:8-12
Approximately 10% of the human transcriptome is composed of circular RNAs (circRNAs). These are non-coding RNA molecules in which a covalent bond between the 3' and 5' forms a stable circular loop. Herein, we profiled the expression of 13,368 cricRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a9dd8525eb56653075abf6c31785b9
https://doi.org/10.1016/j.exphem.2020.04.001
https://doi.org/10.1016/j.exphem.2020.04.001
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e95156 (2014)
INTRODUCTION: Endothelial progenitor cells (EPCs) have an important role in the process of vascular injury repair. Platelets have been shown to mediate EPC recruitment, maturation and differentiation. Yet, the mechanism underlying this interaction is
Externí odkaz:
https://doaj.org/article/d2984125a4ea406ba38defe9780321ee
Autor:
Oren Pasvolsky, Avi Leader, Galit Granot, Ayala Gover-Proaktor, Oshrat Raz, Saar Shapira, Pia Raanani, Metsada Pasmanik-Chor
Publikováno v:
Leukemia & Lymphoma. 60:189-199
The tyrosine kinase inhibitors (TKIs), nilotinib, ponatinib, and dasatinib (but not bosutinib or imatinib), are associated with vascular adverse events (VAEs) in chronic myeloid leukemia (CML). Though the mechanism is inadequately understood, an effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d555b17d2b70c2b772b1a6006c5d0ec8
https://doi.org/10.1080/10428194.2018.1466294
https://doi.org/10.1080/10428194.2018.1466294
Autor:
Galit Granot, Saar Shapira, Ayala Gover-Proaktor, Pia Raanani, Aida Inbal, Oren Pasvolsky, Arnon Nagler, Ido Lubin, Oshrat Raz, Avi Leader, Dorit L. Lev
Publikováno v:
Leukemia & Lymphoma. 58:1455-1467
Tyrosine kinase inhibitors (TKIs) have revolutionized the prognosis of chronic myeloid leukemia. With the advent of highly efficacious therapy, the focus has shifted toward managing TKI adverse effects, such as vascular adverse events (VAEs). We used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219259782e5e19a147edfc5b31bbdf0d
https://doi.org/10.1080/10428194.2016.1239258
https://doi.org/10.1080/10428194.2016.1239258
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S215-S216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9937dd3be99ea9bdb7cf32fc49ebfdd
https://doi.org/10.1016/j.clml.2018.07.079
https://doi.org/10.1016/j.clml.2018.07.079
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e95156 (2014)
PLoS ONE, Vol 9, Iss 6, p e95156 (2014)
Introduction Endothelial progenitor cells (EPCs) have an important role in the process of vascular injury repair. Platelets have been shown to mediate EPC recruitment, maturation and differentiation. Yet, the mechanism underlying this interaction is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac629b49ed6dad4ea36ed478128f106
https://pubmed.ncbi.nlm.nih.gov/24901498
https://pubmed.ncbi.nlm.nih.gov/24901498
Autor:
Gover-Proaktor, Ayala1, Granot, Galit1 galitg@clalit.org.il, Pasmanik-Chor, Metsada2, Pasvolsky, Oren3,4, Shapira, Saar1,4, Raz, Oshrat1, Raanani, Pia3,4, Leader, Avi3,4
Publikováno v:
Leukemia & Lymphoma. Jan2019, Vol. 60 Issue 1, p189-199. 11p.
Autor:
Gover-Proaktor, Ayala1 (AUTHOR), Granot, Galit1 (AUTHOR) galitg@clalit.org.il, Shapira, Saar1,2 (AUTHOR), Raz, Oshrat1 (AUTHOR), Pasvolsky, Oren2,3 (AUTHOR), Nagler, Arnon2,4 (AUTHOR), Lev, Dorit L.1 (AUTHOR), Inbal, Aida3 (AUTHOR), Lubin, Ido1,2 (AUTHOR), Raanani, Pia2,3 (AUTHOR), Leader, Avi2,3 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Jun2017, Vol. 58 Issue 6, p1455-1467. 13p.
Autor:
Raz, Oshrat1,2 oshratra@clalit.org.il, Lev, Dorit L.1,3, Battler, Alexander2, Lev, Eli I.1,2,3
Publikováno v:
PLoS ONE. Jun2014, Vol. 9 Issue 6, p1-8. 8p.
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia; Sep2018:Supplement 1, Vol. 18, pS215-S216, 1p